• 08:30
• 

• Registration & Refreshments

• 09:20
• 

• Chairperson’s opening remarks

  ---

  

  Francis Crawley Executive Director
  Good Clinical Practice Alliance - Europe (GCPA)

Innovation in Pharma

• 09:30
• 

• External Data Acquisition: How to build a Commercial Data Strategy from scratch ?

  • What are the benefits for your organization?
  • Which strategies for efficient collaboration ?
  • How to measure success ?
  • The challenge of data awareness
  • Make or buy ?
    Presentation

  ---

  

  Florent Hassen Global Data Science & Artificial Intelligence Lead
  F. Hoffmann-La Roche

• 10:00
• 

• Pain points to gain points: a case study about how to obtain and apply user feedback to improve digital health products

    Presentation

  ---

  

  Victor Barzey Product Lead, Digital Healthcare
  Otsuka Pharmaceutical Companies Europe

• 10:30
• 

• Business Card Exchange with Morning Coffee/Tea & Discussion

   

       

AI and ML based Drug Discovery

• 10:50
• 

• Quantum Computing for Drug Discovery - Fact or Fiction?

  ---

  

  Ian Pepper Director Technology Innovation
  Novartis

• 11:20
• 

• Fast and Affordable: An AI-Based Platform for High-Throughput Virtual Screening and Molecule Generation with Cloud Scalability

    Presentation

  ---

  

  Alexis Molina Director of Artificial Intelligence
  Nostrum Biodiscovery

• 11:45
• 

• Advances in in-silico experimentation for drug discovery

    Presentation

  ---

  

  Anirudh Patir Associate Scientist
  MSD

• 12:15
• 

• Closing The Loop by Combining Wet Lab Automation and Machine Learning for Accelerated Drug Discovery and Development

    Presentation

  ---

  

  Martin-Immanuel Bittner Co-founder & CEO
  Arctoris

• 12:40
• 

• Luncheon & Networking - Visit Exhibitor Booths & Network with your peers in our Lounge

   

              

• 13:20
• 

• Automatization of AI personalize modeling of multi-modal data integration, analysis, and decision making

    Presentation

  ---

  

  David Camacho-Trujillo CEO
  GeneHolistics

Genomics and Precision Medicine

• 13:50
• 

• Data42: Building a Date Reuse and Analytics Platform for Accelerating the pace of R&D at Novartis

  ---

  

  Gabriel Eichler VP and Head of Data, Data42
  Novartis

• 14:20
• 

• Genomics England Multimodal cancer research platform

  ---

  

  Prabhu Arumugam Director of Clinical Data and Imaging
  Genomics England

• 14:50
• 

• System approach – Combining data for precision health

  ---

  

  Andy Cachaldora General Manager Digital Service Northern Europe
  GE Healthcare

• 15:20
• 

• Grab your Tea/Coffee - Visit our Exhibitor Booths & Network with your colleagues

   

       

Data Science, Big Data & Informatics

• 15:40
• 

• Designing a Data Ecosystem: a Data Product approach

  • Importance of Translational informatics platform in R&D
  • Why is it necessary to adopt TI in the resource –constrained world
  • Challenges ahead and moving forward
    Presentation

  ---

  

  Rafael Laffarga Head of ERP Analytics Finance
  Roche

• 16:10
• 

• Coordination and Optimisation of internal drug development data alongside external data sources

  ---

  

  Thierry Dorval Head of Data Sciences & Data Management
  Servier

• 16:40
• 

• Panel discussion: How Global Pharma is using AI and Machine Learning for success?

  • Innovation in Big-Pharma
  • AI enabled business models in R&D
  • Achieving full potential of AI to boost Drug Discovery and Development
  • AI has the capacity to radically reduce the uncertainty in both early and late-stage drug discovery and development

  ---

  

  Florent Hassen Global Data Science & Artificial Intelligence Lead
  F. Hoffmann-La Roche

  

  Thierry Dorval Head of Data Sciences & Data Management
  Servier

  

  Irena Brookes-Smith Head of Healthcare Analytics
  AstraZeneca

  

  Francis Crawley Executive Director
  Good Clinical Practice Alliance - Europe (GCPA)

• 17:10
• 

• How to prepare your organization for digital health and build new capabilities to drive growth

  ---

  

  Alain Bindels Innovation & Technology Leader
  Roche

• 17:40
• 

• Closing remarks

• 17:50
• 

• Networking Drinks Session

• 08:30
• 

• Registration & Refreshments

• 08:50
• 

• Chairperson’s opening remarks

  ---

  

  Mark Duman Director
  MD Healthcare Consultants

Real World Data & Real World Evidence

• 09:00
• 

• Going all in on AI & technology in a Start-up Launch within Medical Affairs, Can it Work?

   

  Artificial Intelligence is used in many aspects of our daily work in Pharma. Given the large financial investment and how time intensive such projects can be, the business case, vision, and utility need to be tailored to and in line with business needs. This case study will focus upon the deliberate use of AI in a start-up to help improve call center quality, multi-lingual translation, and improved insights collection to accelerate the global launch of our medical affairs services

  • Concrete examples of applied AI in Medical Affairs for successful business launch (e.g., quality monitoring, translations, and performance & customer insights)
  • Optimizing limited global resources at launch with carefully selected AI tools
  • Using real time data to quickly pivot the business where customer need exists
    Presentation

  ---

  

  Michelle Bridenbaker Global Medical Affairs
  Idorsia Pharmaceuticals

• 09:30
• 

• ML/AI-enabled image processing in dermatological research

    Presentation

  ---

  

  Georgios Stamatas Research Associate Director, Essential Health Translational Science
  Johnson & Johnson

• 10:00
• 

• Prognostic biomarker Identification with machine learning modeling on real-world data.

  ---

  

  Naghmeh Ghazaleh Principal Data scientist, Pharma development , Personalized Health Care (PHC)
  Roche

• 10:30
• 

• Business Card Exchange with Morning Coffee/Tea & Discussion

   

       

• 10:50
• 

• A RBM PoC project to assess suitability of RWD as RWE for CTs

  • Tool set: triad python & pandas & Google Collab
  • Population: 7 million (295 cities)/32 variables
  • 27 monthly iterations so far
  • 08 governmental open-source datasets
  • Challenges and learnings using the triad as a ClinOps managerial tool for CTs.
  • Challenges and learnings for feasibility studies of clinical program development & CTs intending to use RWD and/or Machine Learning.
    Presentation

  ---

  

  Aldir Medeiros Filho Former Senior Project Manager - Data Sciences Department
  Mitsubishi Tanabe Pharma Europe Ltd

Data Integration, IoT and Cloud

• 11:20
• 

• Intelligent factory line clearance using AI and Augment Reality.

   

  Conducting a factory line clearance in a pharmaceutical manufactory requires detailed SOPs with procedures that can be difficult to both conduct and document execution of.

  
  In this session we present a way to use a combination of Spatial AI, Computer Vision combined with Synthetic data and augmented reality to both increase quality of cleaning and documentation of execution.

  •  Spatial AI
  • Computer vision
  • Synthetic data
  • Augmented reality
    Presentation

  ---

  

  Leif Elgaard Hoj Chief Technology Officer
  BM TechX

• 11:50
• 

• Challenges in assessing the value of digital health innovations in a Pharmaceutical setting

    Presentation

  ---

  

  Ismael Gauci Personalised Healthcare Strategy & Business Enablement Leader
  Roche

• 12:20
• 

• How AI/Deep Learning is transforming Breast Cancer prediction, detection, diagnosis and treatment.

  ---

  

  Mario Lois Global General Manager, WH Artificial Intelligence & Applied Research
  GE Healthcare

• 12:50
• 

• Luncheon & Networking - Visit Exhibitor Booths & Network with your peers in our Lounge

   

              

• 13:30
• 

• Digihaler Inhaler Case Study and Lessons from Air Crashes

    Presentation

  ---

  

  Mark Milton-Edwards Head of Health Solutions - Digital Health
  Teva Pharmaceuticals

Digital Health in Pharma & Collaboration

• 14:00
• 

• Case Study - AI & Blockchain in Healthcare systems

    Presentation

  ---

  

  Corina Cora Brand Manager
  Takeda

• 14:30
• 

• What is the best organizational structure to enable innovation?

    Presentation

  ---

  

  Pelin Icil Regional Marketing & Business Development Manager
  Boston Scientific

• 15:00
• 

• Achieving pervasive process orchestration in drug safety and beyond

    Presentation

  ---

  

  Martin Holm-Petersen CEO
  Insife

• 15:30
• 

• Grab your Tea/Coffee - Visit our Exhibitor Booths & Network with your colleagues

   

       

• 15:50
• 

• Panel Discussion: Emerging technologies and how pharma-health collaboration works on innovating drug discovery & patient experience

  • Why is it important for pharma and healthcare to work together?
  • The changing patient behaviour in the digital era
  • Why is it essential to be prompt in identifying and addressing the patient’s needs?
  • How will digitization help bring patients on board?
  • Progress made by companies so far
  • Strategies to be adopted to increase patient –company data flow

  ---

  

  Mark Milton-Edwards Head of Health Solutions - Digital Health
  Teva Pharmaceuticals

  

  Pelin Icil Regional Marketing & Business Development Manager
  Boston Scientific

  

  Corina Cora Brand Manager
  Takeda

  

  Neeraj Goel Mittal Senior Director - Global Data, Analytics & AI (ViiV Healthcare)
  GSK

  

  Mark Duman Director
  MD Healthcare Consultants

• 16:20
• 

• Digital Transformation in Pharma

    Presentation

  ---

  

  Shruthi Bharadwaj Head, Science and Technology Intelligence
  Sanofi

• 16:50
• 

• What’s the digital transformation and in which way Innovation could do the difference in the Pharma industry?

  ---

  

  Stefania Alvino Head of digital innovation
  Daiichi Sankyo Italia S.p.A

• 17:10
• 

• Chairperson’s Closing Remark

  ---

  

  Mark Duman Director
  MD Healthcare Consultants